Quantum Biopharma, InMed Pharmaceuticals, and Innovative Industrial Properties are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are publicly traded shares of companies involved in the cultivation, processing, distribution or retail sale of cannabis and hemp-derived products. Their performance is closely tied to evolving regulatory environments, shifts in legalization policy and consumer demand, often resulting in higher volatility and growth potential compared with more established sectors. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Quantum Biopharma (QNTM)
Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.
Shares of QNTM stock traded down $2.81 during trading on Wednesday, reaching $24.32. The company's stock had a trading volume of 220,958 shares, compared to its average volume of 942,489. The company has a market capitalization of $70.77 million, a price-to-earnings ratio of -1.53 and a beta of 0.55. The stock's 50-day moving average price is $12.95 and its 200 day moving average price is $8.11. Quantum Biopharma has a 1-year low of $2.70 and a 1-year high of $38.25.
Read Our Latest Research Report on QNTM
InMed Pharmaceuticals (INM)
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry.
Shares of INM traded down $0.04 during mid-day trading on Wednesday, hitting $3.84. The company had a trading volume of 1,354,527 shares, compared to its average volume of 994,510. The stock has a market cap of $4.64 million, a PE ratio of -0.31 and a beta of 0.17. InMed Pharmaceuticals has a 1-year low of $1.72 and a 1-year high of $15.70. The business's 50-day simple moving average is $2.81 and its 200-day simple moving average is $3.26. The company has a quick ratio of 3.04, a current ratio of 3.49 and a debt-to-equity ratio of 0.06.
Read Our Latest Research Report on INM
Innovative Industrial Properties (IIPR)
IIPR traded down $0.61 during midday trading on Wednesday, reaching $58.29. The company's stock had a trading volume of 74,854 shares, compared to its average volume of 276,791. The company has a fifty day simple moving average of $55.21 and a 200 day simple moving average of $64.86. The stock has a market cap of $1.63 billion, a P/E ratio of 11.20 and a beta of 1.70. The company has a current ratio of 10.73, a quick ratio of 10.73 and a debt-to-equity ratio of 0.15. Innovative Industrial Properties has a twelve month low of $45.44 and a twelve month high of $138.35.
Read Our Latest Research Report on IIPR
Recommended Stories
Before you consider Quantum Biopharma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum Biopharma wasn't on the list.
While Quantum Biopharma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
